XBiotech Inc.
NASDAQ:XBITBiotechnology
Healthcare
$1.68 -0.84%
-$0.02 today
- Market cap
- $51.22M
- Beta
- 0.84
- P/E (TTM)
- -1.8
- EPS (TTM)
- -$1.32
52W Low $2.09High $3.61
Volume 0.05M
Average 0.03M
Cash Flow
Check whether earnings turn into cash.
Operating Cash Flow
-$39.92M
FY 2025 · Annual
Investing Cash Flow
-$289,000.00
FY 2025 · Annual
Financing Cash Flow
-$10.25M
FY 2025 · Annual
Cash Flow Statement
USD
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (17.41M) | (32.9M) | (24.56M) | (38.53M) | (45.54M) |
| Depreciation & Amortization | 2.65M | 2.61M | 1.74M | 1.75M | 1.69M |
| Deferred Income Tax | 0 | 0 | 0 | 0 | 5K |
| Stock-Based Compensation | 4.46M | 5.06M | 3.26M | 1.75M | 3.62M |
| Change in Working Capital | 79.75M | 7.6M | 2.72M | (1.46M) | 3.64M |
| Accounts Receivables | 1.73M | 7.34M | 829K | 77K | 574K |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Accounts Payables | (514K) | 357K | 91K | (364K) | (688K) |
| Other Working Capital | 78.53M | (97K) | 1.8M | (1.17M) | 3.75M |
| Other Non-Cash Items | 4.46M | 2.8M | (1.89M) | 5.53M | (3.33M) |
| Operating Cash Flow | 69.45M | (14.82M) | (18.73M) | (30.96M) | (39.92M) |
| Capital Expenditures | (3.53M) | (585K) | (362K) | (1.3M) | (289K) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | 0 | (63.31M) | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 0 | 61.86M | 0 | 0 |
| Investing Cash Flow | (3.53M) | (63.89M) | 61.5M | (1.3M) | (289K) |
| Debt Repayment | 0 | 0 | 0 | 10.25M | (10.25M) |
| Common Stock Issued | 0 | 0 | 5K | 0 | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | (75M) | 0 | 0 | 0 | 0 |
| Other Financing Activities | 8M | 0 | (14K) | 200K | 0 |
| Financing Cash Flow | (67.01M) | 0 | (9K) | 10.45M | (10.25M) |
| Effect of Forex Changes | 705K | (961K) | (46K) | (5.53M) | 3.33M |
| Net Change in Cash | (383K) | (79.68M) | 42.72M | (27.35M) | (47.13M) |
| Free Cash Flow | 65.92M | (15.41M) | (19.09M) | (32.27M) | (40.21M) |
Free Cash Flow
Net Income to FCF bridge
FY2025
= Net Income-$45.5M
+ D&A$1.7M
+ Stock-Based Comp$3.6M
+ Deferred Tax$5.0K
+ Working Capital$3.6M
- Other Non-Cash-$3.3M
= Operating Cash Flow-$39.9M
- Capex-$289.0K
= Free Cash Flow-$40.2M
Analysis
FY2025 free cash flow is -$40.2M. FCF conversion is 88.3% of net income. Operating cash flow was -$39.9M, with capex of -$289.0K. The largest bridge item is Working Capital at $3.6M.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 4 | Statement of changes in beneficial ownership | Nov 13, 2026 | |
| 10-Q | Quarterly report | Nov 12, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 | |
| 3 | Initial statement of beneficial ownership | Oct 28, 2026 | |
| 4 | Statement of changes in beneficial ownership | Oct 28, 2026 |
Does XBIT generate free cash flow?
XBiotech Inc. (XBIT) generated -$40.21M of free cash flow in fiscal 2025.
How much operating cash flow does XBIT produce?
Operating cash flow was -$39.92M, before capital expenditures of $289,000.00.
Continue the stock analysis
Jump to another research area for this company.